The company aims to broadly offer DNA from the fully-automated, miniaturized, high-throughput, clinical-ready DNA production platform later next year MENLO PARK, Calif.–#CGT—Elegen, a global leader in next-generation cell-free DNA manufacturing, today announced the early access launch of its Gen II DNA Production Platform. This platform now incorporates the world’s first directed split-pool microfluidic synthesizer, which […]

FREMONT, Calif. — Ultima Genomics, a developer of an innovative, ultra-high throughput sequencing architecture, today announced that Jason Kang, an industry veteran has joined as the Company’s commercial leader in the APAC region. This appointment follows strong global adoption of Ultima’s technology for clinical and research applications and supports Ultima’s growth in the APAC region. […]

Adam S. Elinoff, Chief Financial Officer, Agilent Technologies SANTA CLARA, Calif. — Agilent Technologies Inc. (NYSE: A) today announced the appointment of Adam S. Elinoff as chief financial officer, effective Nov. 17. Elinoff brings two decades of financial experience spanning corporate finance, investor relations, strategy and business transformation, and has a proven record of driving […]

Company is first to deliver ultra-long, fully verified DNA in less than 25 days, backed by the industry’s only on-time guarantee EMERYVILLE, Calif. — #50kb–Ansa Biotechnologies, the trusted partner for DNA synthesis, today announced the global launch of its 50 kilobase (kb) Clonal DNA product, the longest sequence-perfect synthetic DNA commercially available. Powered by the company’s […]

CAMBRIDGE, England & LOS ANGELES — Molecular Instruments® (MI) and Abcam today announced that MI’s newly introduced HCR™ HiFi Encoder is broadly compatible with Abcam’s portfolio of RabMAb® and mouse primary antibodies. This collaboration combines Abcam’s extensive catalog of best-in-class primary antibodies with MI’s state-of-the-art amplification technology, offering researchers a powerful new approach to multiplex […]

BOSTON and ROLLE, Switzerland — SOPHiA GENETICS (Nasdaq: SOPH), a leader in AI-driven precision medicine, today announced the launch of SOPHiA DDM™ Digital Twins, a breakthrough research technology that creates dynamic, virtual representations of individual patients to simulate potential outcomes and help oncologists make better treatment decisions.   SOPHiA DDM™ Digital Twins uses each patient’s unique […]

HERCULES, Calif.–Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global leader in life science research and clinical diagnostics products, today announced that MicroVal, the international certification organization for the validation and approval of alternative methods for the microbiological analysis of food and beverages, has approved iQ-Check™ Enterobacteriaceae Kit for the real-time PCR detection of Enterobacteriaceae (EB) in infant formula, infant cereal […]

Lausanne — Sciencewerke, a leading provider of biomedical and life science solutions, is proud to announce its appointment as the official distributor for VarSome, the comprehensive platform for genomic variant interpretation and analysis, in Singapore, Malaysia, Indonesia, and Thailand. Developed by Saphetor, VarSome is a globally trusted bioinformatics resource used by thousands of researchers, clinicians, and diagnostic […]

WALTHAM, Mass. —  Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced plans to further increase the impact of Thermo Fisher’s proven growth strategy through the use of artificial intelligence (AI) with OpenAI. This collaboration will help to improve the speed and success of drug development, enabling customers to get medicines […]

ROLLE, Switzerland and TOKYO — A.D.A.M. Innovations, Japan’s leading private genetic testing company, and SOPHiA GENETICS (Nasdaq: SOPH), an AI technology company pioneering data-driven medicine, today announced at ESMO a strategic agreement to bring cutting-edge liquid biopsy genomic testing to the Japanese population. The companies will also partner to commercialize a liquid biopsy companion diagnostic aimed at advancing personalized and […]